Shigella flexneri suppresses NF-κB activation by inhibiting linear ubiquitin chain ligation

Nature Microbiology

Volumn 1, Issue 7, 2016, Pages

  De Jong, Maarten F ^a   Liu, Zixu ^a   Chen, Didi ^a   Alto, Neal M ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; RNF31 PROTEIN, HUMAN; TUMOR NECROSIS FACTOR; UBIQUITIN; UBIQUITIN PROTEIN LIGASE;

ANIMAL; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNE EVASION; IMMUNOLOGY; INNATE IMMUNITY; METABOLISM; MOUSE; PATHOGENICITY; SHIGELLA FLEXNERI; SIGNAL TRANSDUCTION; TYPE III SECRETION SYSTEM; UBIQUITINATION;

ANIMALS; GENE EXPRESSION REGULATION; HUMANS; IMMUNE EVASION; IMMUNITY, INNATE; INTERLEUKIN-1BETA; MICE; NF-KAPPA B; SHIGELLA FLEXNERI; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA; TYPE III SECRETION SYSTEMS; UBIQUITIN; UBIQUITIN-PROTEIN LIGASES; UBIQUITINATION;

EID: 84991404802     PISSN: None     EISSN: 20585276     Source Type: Journal    
DOI: 10.1038/nmicrobiol.2016.84     Document Type: Article

References (46)

1. Gerlach, B. et al. Linear ubiquitination prevents inflammation and regulates immune signalling. Nature 471, 591-596 (2011).
2. Haas, T. L. et al. Recruitment of the linear ubiquitin chain assembly complex stabilizes the TNF-R1 signaling complex and is required for TNF-mediated gene induction. Mol. Cell 36, 831-844 (2009).
3. Ikeda, F. et al. SHARPIN forms a linear ubiquitin ligase complex regulating NF-κB activity and apoptosis. Nature 471, 637-641 (2011).
4. Walczak, H., Iwai, K. & Dikic, I. Generation and physiological roles of linear ubiquitin chains. BMC Biology 10, 23 (2012).
5. Rieser, E., Cordier, S. M. & Walczak, H. Linear ubiquitination: a newly discovered regulator of cell signalling. Trends Biochem. Sci. 38, 94-102 (2013).
6. Rahighi, S. et al. Specific recognition of linear ubiquitin chains by NEMO is important for NF-κB activation. Cell 136, 1098-1109 (2009).
7. Tokunaga, F. et al. Involvement of linear polyubiquitylation of NEMO in NF-κB activation. Nature Cell Biol. 11, 123-132 (2009).
8. Boisson, B. et al. Human HOIP and LUBAC deficiency underlies autoinflammation, immunodeficiency, amylopectinosis, and lymphangiectasia. J. Exp. Med. 212, 939-951 (2015).
9. Boisson, B. et al. Immunodeficiency, autoinflammation and amylopectinosis in humans with inherited HOIL-1 and LUBAC deficiency. Nature Immunol. 13, 1178-1186 (2012).
10. Reddick, L. E. & Alto, N. M. Bacteria fighting back: how pathogens target and subvert the host innate immune system. Mol. Cell 54, 321-328 (2014).
11. Kotloff, K. L. et al. Global burden of Shigella infections: implications for vaccine development and implementation of control strategies. Bull. World Health Organ. 77, 651-666 (1999).
12. Lan, R., Alles, M. C., Donohoe, K., Martinez, M. B. & Reeves, P. R. Molecular evolutionary relationships of enteroinvasive Escherichia coli and Shigella spp. Infect. Immun. 72, 5080-5088 (2004).
13. Ashida, H. et al. A bacterial E3 ubiquitin ligase Ipa H9.8 targets NEMO/IKKγ to dampen the host NF-κB-mediated inflammatory response. Nature Cell Biol. 12, 66-73 (2010).
14. Buchrieser, C. et al. The virulence plasmid pWR100 and the repertoire of proteins secreted by the type III secretion apparatus of Shigella flexneri. Mol. Microbiol. 38, 760-771 (2000).
15. Ashida, H., Nakano, H. & Sasakawa, C. Shigella Ipa H0722 E3 ubiquitin ligase effector targets TRAF2 to inhibit PKC-NF-κB activity in invaded epithelial cells. PLoS Pathogens 9, e1003409 (2013).
16. Kim, D. W. et al. The Shigella flexneri effector OspG interferes with innate immune responses by targeting ubiquitin-conjugating enzymes. Proc. Natl Acad. Sci. USA 102, 14046-14051 (2005).
17. Sanada, T. et al. The Shigella flexneri effector OspI deamidates UBC13 to dampen the inflammatory response. Nature 483, 623-626 (2012).
18. Newton, H. J. et al. The type III effectors NleE and NleB from enteropathogenic E. coli and OspZ from Shigella block nuclear translocation of NF-κB p65. PLoS Pathogens 6, e1000898 (2010).
19. Zhang, L. et al. Cysteine methylation disrupts ubiquitin-chain sensing in NF-κB activation. Nature 481, 204-208 (2012).
20. Emmerich, C. H. et al. Activation of the canonical IKK complex by K63/M1-linked hybrid ubiquitin chains. Proc. Natl Acad. Sci. USA 110, 15247-15252 (2013).
21. Rohde, J. R., Breitkreutz, A., Chenal, A., Sansonetti, P. J. & Parsot, C. Type III secretion effectors of the IpaH family are E3 ubiquitin ligases. Cell Host Microbe 1, 77-83 (2007).
22. Zhu, Y. et al. Structure of a Shigella effector reveals a new class of ubiquitin ligases. Nature Struct. Mol. Biol. 15, 1302-1308 (2008).
23. Pruneda, J. N. et al. E2-Ub conjugates regulate the kinase activity of Shigella effector OspG during pathogenesis. EMBO J. 33, 437-449 (2014).
24. Zhou, Y., Dong, N., Hu, L. & Shao, F. The Shigella type three secretion system effector OspG directly and specifically binds to host ubiquitin for activation. PLoS ONE 8, e57558 (2013).
25. Uekusa, Y. et al. Backbone and side chain 1H, 13C, and 15N assignments of the ubiquitin-like domain of human HOIL-1L, an essential component of linear ubiquitin chain assembly complex. Biomol. NMR Assign. 6, 177-180 (2012).
26. Yagi, H. et al. A non-canonical UBA-UBL interaction forms the linear ubiquitin-chain assembly complex. EMBO Rep. 13, 462-468 (2012).
27. Smit, J. J. et al. The E3 ligase HOIP specifies linear ubiquitin chain assembly through its RING-IBR-RING domain and the unique LDD extension. EMBO J. 31, 3833-3844 (2012).
28. Keszei, A. F. et al. Structure of an SspH1-PKN1 complex reveals the basis for host substrate recognition and mechanism of activation for a bacterial E3 ubiquitin ligase. Mol. Cell. Biol. 34, 362-373 (2014).
29. Chau, V. et al. A multiubiquitin chain is confined to specific lysine in a targeted short-lived protein. Science 243, 1576-1583 (1989).
30. Ashida, H., Toyotome, T., Nagai, T. & Sasakawa, C. Shigella chromosomal IpaH proteins are secreted via the type III secretion system and act as effectors. Mol. Microbiol. 63, 680-693 (2007).
31. Wang, F. et al. Shigella flexneri T3SS effector IpaH4.5 modulates the host inflammatory response via interaction with NF-κB p65 protein. Cell. Microbiol.15, 474-485 (2013).
32. Haraga, A. & Miller, S. I. A Salmonella type III secretion effector interacts with the mammalian serine/threonine protein kinase PKN1. Cell. Microbiol. 8, 837-846 (2006).
33. Damgaard, R. B. et al. The ubiquitin ligase XIAP recruits LUBAC for NOD2 signaling in inflammation and innate immunity. Mol. Cell 46, 746-758 (2012).
34. Gurung, P., Lamkanfi, M. & Kanneganti, T. D. Cutting edge: SHARPIN is required for optimal NLRP3 inflammasome activation. J. Immunol. 194, 2064-2067 (2015).
35. Rodgers, M. A. et al. The linear ubiquitin assembly complex (LUBAC) is essential for NLRP3 inflammasome activation. J. Exp. Med. 211, 1333-1347 (2014).
36. Tokunaga, F. et al. SHARPIN is a component of the NF-κB-activating linear ubiquitin chain assembly complex. Nature 471, 633-636 (2011).
37. Raqib, R., Wretlind, B., Andersson, J. & Lindberg, A. A. Cytokine secretion in acute shigellosis is correlated to disease activity and directed more to stool than to plasma. J. Infect. Dis. 171, 376-384 (1995).
38. Speelman, P., Kabir, I. & Islam, M. Distribution and spread of colonic lesions in shigellosis: a colonoscopic study. J. Infect. Dis. 150, 899-903 (1984).
39. Islam, D. et al. Downregulation of bactericidal peptides in enteric infections: a novel immune escape mechanism with bacterial DNA as a potential regulator. Nature Med. 7, 180-185 (2001).
40. Sperandio, B. et al. Virulent Shigella flexneri subverts the host innate immune response through manipulation of antimicrobial peptide gene expression. J. Exp. Med. 205, 1121-1132 (2008).
41. Fields, S. & Song, O. A novel genetic system to detect protein-protein interactions. Nature 340, 245-246 (1989).
42. Hollenberg, S. M., Sternglanz, R., Cheng, P. F. & Weintraub, H. Identification of a new family of tissue-specific basic helix-loop-helix proteins with a two-hybrid system. Mol. Cell. Biol. 15, 3813-3822 (1995).
43. Datsenko, K. A. & Wanner, B. L. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc. Natl Acad. Sci. USA 97, 6640-6645 (2000).
44. Lauer, P., Chow, M. Y., Loessner, M. J., Portnoy, D. A. & Calendar, R. Construction, characterization, and use of two Listeria monocytogenes site-specific phage integration vectors. J. Bacteriol. 184, 4177-4186 (2002).
45. Sanjana, N. E., Shalem, O. & Zhang, F. Improved vectors and genome-wide libraries for CRISPR screening. Nature Methods 11, 783-784 (2014).
46. Shalem, O. et al. Genome-scale CRISPR-Cas9 knockout screening in human cells. Science 343, 84-87 (2014).